| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10688 | 2021 |
| Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes GF Lewis, A Carpentier, K Adeli, A Giacca Endocrine reviews 23 (2), 201-229, 2002 | 1914 | 2002 |
| Fructose, insulin resistance, and metabolic dyslipidemia H Basciano, L Federico, K Adeli Nutrition & metabolism 2, 1-14, 2005 | 1273 | 2005 |
| Hepatic insulin resistance, metabolic syndrome and cardiovascular disease R Meshkani, K Adeli Clinical biochemistry 42 (13-14), 1331-1346, 2009 | 594 | 2009 |
| Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome MJ Dekker, Q Su, C Baker, AC Rutledge, K Adeli American Journal of Physiology-Endocrinology and Metabolism, 2010 | 546 | 2010 |
| Peer review in scientific publications: benefits, critiques, & a survival guide J Kelly, T Sadeghieh, K Adeli Ejifcc 25 (3), 227, 2014 | 544 | 2014 |
| Tocotrienol: a review of its therapeutic potential A Theriault, JT Chao, QI Wang, A Gapor, K Adeli Clinical Biochemistry 32 (5), 309-319, 1999 | 501 | 1999 |
| Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children DA Colantonio, L Kyriakopoulou, MK Chan, CH Daly, D Brinc, AA Venner, ... Clinical chemistry 58 (5), 854-868, 2012 | 491 | 2012 |
| Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms AC Rutledge, K Adeli Nutrition reviews 65, S13-S23, 2007 | 437 | 2007 |
| Lipid and lipoprotein dysregulation in insulin resistant states RK Avramoglu, H Basciano, K Adeli Clinica chimica acta 368 (1-2), 1-19, 2006 | 436 | 2006 |
| Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance C Taghibiglou, A Carpentier, SC Van Iderstine, B Chen, D Rudy, A Aiton, ... Journal of Biological Chemistry 275 (12), 8416, 2000 | 431 | 2000 |
| Heavy metals in the environment B Sarkar CRC Press, 2002 | 398 | 2002 |
| Pathophysiology of COVID-19: mechanisms underlying disease severity and progression MK Bohn, A Hall, L Sepiashvili, B Jung, S Steele, K Adeli Physiology 35 (5), 288-301, 2020 | 318 | 2020 |
| The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice J Hsieh, C Longuet, CL Baker, B Qin, LM Federico, DJ Drucker, K Adeli Diabetologia 53, 552-561, 2010 | 314 | 2010 |
| Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance M Haidari, N Leung, F Mahbub, KD Uffelman, R Kohen-Avramoglu, ... Journal of Biological Chemistry 277 (35), 31646-31655, 2002 | 307 | 2002 |
| Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a … C Taghibiglou, F Rashid-Kolvear, SC Van Iderstine, H Le-Tien, IG Fantus, ... Journal of Biological Chemistry 277 (1), 793-803, 2002 | 295 | 2002 |
| Dietary fructose and the metabolic syndrome A Miller, K Adeli Current opinion in gastroenterology 24 (2), 204, 2008 | 290 | 2008 |
| Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters B Dong, M Wu, H Li, FB Kraemer, K Adeli, NG Seidah, SW Park, J Liu Journal of lipid research 51 (6), 1486-1495, 2010 | 284 | 2010 |
| Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance K Adeli, C Taghibiglou, SC Van Iderstine, GF Lewis Trends in cardiovascular medicine 11 (5), 170-176, 2001 | 256 | 2001 |
| Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36 J Hsieh, C Longuet, A Maida, J Bahrami, E Xu, CL Baker, PL Brubaker, ... Gastroenterology 137 (3), 997-1005. e4, 2009 | 255 | 2009 |
